Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tanzania | 40 | 2023 | 1407 | 1.380 |
Why?
|
| Nutritional Status | 7 | 2018 | 1620 | 0.730 |
Why?
|
| Zinc | 4 | 2023 | 675 | 0.720 |
Why?
|
| HIV Infections | 24 | 2023 | 17533 | 0.690 |
Why?
|
| Antiretroviral Therapy, Highly Active | 5 | 2018 | 1899 | 0.640 |
Why?
|
| Vitamins | 6 | 2022 | 1630 | 0.630 |
Why?
|
| Gastroesophageal Reflux | 6 | 2022 | 833 | 0.610 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2018 | 292 | 0.510 |
Why?
|
| Infectious Disease Transmission, Vertical | 5 | 2016 | 1354 | 0.510 |
Why?
|
| Anti-HIV Agents | 10 | 2016 | 4559 | 0.510 |
Why?
|
| Infant Nutritional Physiological Phenomena | 5 | 2019 | 352 | 0.500 |
Why?
|
| Child Development | 5 | 2023 | 2327 | 0.480 |
Why?
|
| Dietary Supplements | 6 | 2023 | 3425 | 0.470 |
Why?
|
| Growth Disorders | 6 | 2022 | 633 | 0.460 |
Why?
|
| Biliary Tract Neoplasms | 4 | 2011 | 186 | 0.400 |
Why?
|
| Vitamin D | 3 | 2011 | 3272 | 0.400 |
Why?
|
| Diet | 7 | 2018 | 8086 | 0.370 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2015 | 392 | 0.370 |
Why?
|
| Premature Birth | 5 | 2022 | 1829 | 0.340 |
Why?
|
| Anemia | 3 | 2023 | 1511 | 0.340 |
Why?
|
| Pregnancy Outcome | 6 | 2022 | 2966 | 0.340 |
Why?
|
| Dyslipidemias | 3 | 2013 | 869 | 0.310 |
Why?
|
| Diarrhea | 4 | 2020 | 1316 | 0.290 |
Why?
|
| Gastroparesis | 2 | 2022 | 143 | 0.280 |
Why?
|
| Pregnancy | 22 | 2023 | 30260 | 0.280 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2016 | 2187 | 0.280 |
Why?
|
| Colitis, Ulcerative | 2 | 2023 | 1915 | 0.270 |
Why?
|
| Flagellin | 2 | 2018 | 124 | 0.260 |
Why?
|
| Infant | 27 | 2023 | 36386 | 0.250 |
Why?
|
| Immunoglobulin A | 3 | 2023 | 995 | 0.250 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2019 | 395 | 0.240 |
Why?
|
| Insulin Resistance | 2 | 2009 | 3985 | 0.240 |
Why?
|
| CD4 Lymphocyte Count | 6 | 2018 | 2587 | 0.230 |
Why?
|
| Infant, Low Birth Weight | 2 | 2022 | 871 | 0.230 |
Why?
|
| Blood Glucose | 5 | 2022 | 6424 | 0.220 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 506 | 0.220 |
Why?
|
| Breast Feeding | 5 | 2020 | 1364 | 0.220 |
Why?
|
| Female | 64 | 2023 | 396112 | 0.220 |
Why?
|
| Body Mass Index | 7 | 2022 | 13039 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2015 | 2047 | 0.200 |
Why?
|
| Tuberculosis | 1 | 2015 | 2012 | 0.200 |
Why?
|
| Glucose Tolerance Test | 3 | 2010 | 1180 | 0.190 |
Why?
|
| Lipids | 1 | 2013 | 3315 | 0.190 |
Why?
|
| Diet Records | 3 | 2018 | 425 | 0.190 |
Why?
|
| Turner Syndrome | 1 | 2023 | 129 | 0.190 |
Why?
|
| Puberty, Delayed | 1 | 2022 | 124 | 0.190 |
Why?
|
| Humans | 81 | 2023 | 765968 | 0.190 |
Why?
|
| Bronchiectasis | 1 | 2022 | 141 | 0.180 |
Why?
|
| Laryngomalacia | 1 | 2021 | 32 | 0.180 |
Why?
|
| Esophagitis, Peptic | 1 | 2021 | 77 | 0.180 |
Why?
|
| Antidiarrheals | 1 | 2020 | 46 | 0.180 |
Why?
|
| Anti-Ulcer Agents | 1 | 2021 | 112 | 0.180 |
Why?
|
| Botulinum Toxins | 1 | 2022 | 191 | 0.170 |
Why?
|
| Pregnant Women | 2 | 2022 | 575 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2023 | 2268 | 0.170 |
Why?
|
| Infant, Newborn | 14 | 2022 | 26346 | 0.170 |
Why?
|
| Risk Factors | 26 | 2022 | 74840 | 0.170 |
Why?
|
| Lung Transplantation | 2 | 2021 | 1311 | 0.170 |
Why?
|
| Pregnancy Complications | 3 | 2022 | 2975 | 0.170 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2021 | 116 | 0.170 |
Why?
|
| Infant Mortality | 2 | 2016 | 751 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 380 | 0.160 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 390 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 2216 | 0.160 |
Why?
|
| Micronutrients | 1 | 2022 | 390 | 0.160 |
Why?
|
| Gastric Emptying | 2 | 2022 | 247 | 0.160 |
Why?
|
| Adult | 35 | 2022 | 223044 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 2 | 2018 | 1203 | 0.150 |
Why?
|
| Child | 21 | 2023 | 80564 | 0.150 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 374 | 0.150 |
Why?
|
| Crohn Disease | 2 | 2022 | 2283 | 0.150 |
Why?
|
| Multivariate Analysis | 6 | 2018 | 12056 | 0.150 |
Why?
|
| Mesalamine | 2 | 2023 | 134 | 0.150 |
Why?
|
| Hemoglobins | 3 | 2014 | 1530 | 0.150 |
Why?
|
| Male | 48 | 2022 | 363698 | 0.150 |
Why?
|
| Respiratory System | 1 | 2021 | 559 | 0.150 |
Why?
|
| Stillbirth | 2 | 2022 | 381 | 0.150 |
Why?
|
| Milk, Human | 3 | 2022 | 490 | 0.150 |
Why?
|
| Prospective Studies | 19 | 2022 | 54802 | 0.150 |
Why?
|
| Microcephaly | 1 | 2022 | 426 | 0.140 |
Why?
|
| Sex Factors | 7 | 2018 | 10603 | 0.140 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2015 | 838 | 0.140 |
Why?
|
| Interferons | 1 | 2021 | 714 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 388 | 0.140 |
Why?
|
| Overweight | 4 | 2018 | 2444 | 0.140 |
Why?
|
| Iron | 2 | 2023 | 1816 | 0.140 |
Why?
|
| Enteral Nutrition | 2 | 2022 | 803 | 0.140 |
Why?
|
| Child, Preschool | 13 | 2023 | 42500 | 0.140 |
Why?
|
| Longitudinal Studies | 7 | 2022 | 14751 | 0.130 |
Why?
|
| Intestine, Small | 2 | 2022 | 1214 | 0.130 |
Why?
|
| Thinness | 2 | 2018 | 482 | 0.130 |
Why?
|
| Respiratory Tract Infections | 2 | 2017 | 1008 | 0.130 |
Why?
|
| Diarrhea, Infantile | 2 | 2020 | 100 | 0.130 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 101 | 0.130 |
Why?
|
| Cholesterol | 3 | 2017 | 2898 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 2429 | 0.130 |
Why?
|
| Iron, Dietary | 1 | 2016 | 148 | 0.130 |
Why?
|
| Folic Acid | 1 | 2022 | 1338 | 0.130 |
Why?
|
| Primary Graft Dysfunction | 1 | 2017 | 112 | 0.130 |
Why?
|
| Thyroidectomy | 1 | 2021 | 916 | 0.130 |
Why?
|
| Infant Nutrition Disorders | 2 | 2018 | 70 | 0.120 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 285 | 0.120 |
Why?
|
| Inflammation | 5 | 2022 | 10850 | 0.120 |
Why?
|
| Models, Statistical | 1 | 2010 | 5089 | 0.120 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 639 | 0.120 |
Why?
|
| Gallstones | 3 | 2011 | 285 | 0.120 |
Why?
|
| Blood Pressure | 3 | 2017 | 8532 | 0.120 |
Why?
|
| Body Height | 2 | 2018 | 1562 | 0.120 |
Why?
|
| Gestational Age | 3 | 2021 | 3609 | 0.120 |
Why?
|
| Cooking | 1 | 2017 | 327 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2018 | 2531 | 0.120 |
Why?
|
| Lamivudine | 1 | 2016 | 368 | 0.110 |
Why?
|
| Prevalence | 7 | 2021 | 15842 | 0.110 |
Why?
|
| Weight Gain | 3 | 2022 | 2355 | 0.110 |
Why?
|
| Tea | 2 | 2006 | 290 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2019 | 959 | 0.110 |
Why?
|
| Diet Surveys | 1 | 2018 | 1159 | 0.110 |
Why?
|
| Models, Biological | 1 | 2010 | 9443 | 0.110 |
Why?
|
| Calcium, Dietary | 1 | 2016 | 526 | 0.110 |
Why?
|
| Adolescent | 15 | 2023 | 88835 | 0.110 |
Why?
|
| Triglycerides | 3 | 2011 | 2441 | 0.110 |
Why?
|
| Double-Blind Method | 6 | 2020 | 12437 | 0.110 |
Why?
|
| Leptin | 1 | 2021 | 1596 | 0.110 |
Why?
|
| Aspirin | 1 | 2005 | 3134 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2023 | 10383 | 0.100 |
Why?
|
| Energy Intake | 2 | 2018 | 2141 | 0.100 |
Why?
|
| Developing Countries | 2 | 2022 | 2911 | 0.100 |
Why?
|
| China | 7 | 2011 | 2385 | 0.100 |
Why?
|
| Self Care | 1 | 2018 | 800 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 4058 | 0.100 |
Why?
|
| Anthropometry | 1 | 2017 | 1338 | 0.100 |
Why?
|
| Obesity | 6 | 2018 | 13076 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 513 | 0.100 |
Why?
|
| Middle Aged | 21 | 2018 | 223009 | 0.100 |
Why?
|
| Gallbladder Neoplasms | 2 | 2011 | 189 | 0.100 |
Why?
|
| Proportional Hazards Models | 7 | 2018 | 12509 | 0.090 |
Why?
|
| Benchmarking | 1 | 2018 | 1052 | 0.090 |
Why?
|
| Testosterone | 1 | 2022 | 2494 | 0.090 |
Why?
|
| Urban Health | 3 | 2009 | 530 | 0.090 |
Why?
|
| Young Adult | 12 | 2022 | 59889 | 0.090 |
Why?
|
| Age Factors | 5 | 2021 | 18380 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 866 | 0.090 |
Why?
|
| Cohort Studies | 11 | 2022 | 41649 | 0.090 |
Why?
|
| Immunosuppressive Agents | 2 | 2022 | 4209 | 0.090 |
Why?
|
| Prenatal Care | 1 | 2018 | 1160 | 0.090 |
Why?
|
| Celiac Disease | 1 | 2018 | 820 | 0.090 |
Why?
|
| Cross-Sectional Studies | 8 | 2018 | 26318 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1808 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2016 | 2652 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1884 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2023 | 4528 | 0.080 |
Why?
|
| Placebos | 1 | 2013 | 1659 | 0.080 |
Why?
|
| Hospitalization | 4 | 2022 | 10808 | 0.080 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 39193 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15880 | 0.080 |
Why?
|
| Health Status | 2 | 2011 | 4080 | 0.070 |
Why?
|
| Vomiting | 2 | 2022 | 647 | 0.070 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 2371 | 0.070 |
Why?
|
| Hypertension | 3 | 2017 | 8626 | 0.070 |
Why?
|
| Treatment Outcome | 10 | 2022 | 65188 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 3446 | 0.070 |
Why?
|
| Placenta | 1 | 2016 | 1728 | 0.070 |
Why?
|
| Dietary Sucrose | 1 | 2009 | 241 | 0.070 |
Why?
|
| Environment | 3 | 2018 | 1114 | 0.070 |
Why?
|
| HIV-1 | 2 | 2016 | 6944 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2022 | 81514 | 0.070 |
Why?
|
| Anti-Retroviral Agents | 2 | 2014 | 1787 | 0.070 |
Why?
|
| Algorithms | 3 | 2021 | 14071 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2023 | 1896 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 12240 | 0.060 |
Why?
|
| Meat | 1 | 2009 | 588 | 0.060 |
Why?
|
| Fasting | 1 | 2011 | 1606 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2014 | 1393 | 0.060 |
Why?
|
| Research Design | 1 | 2021 | 6209 | 0.060 |
Why?
|
| Protective Agents | 1 | 2005 | 151 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6203 | 0.060 |
Why?
|
| Logistic Models | 5 | 2021 | 13266 | 0.060 |
Why?
|
| Insulin | 2 | 2009 | 6599 | 0.060 |
Why?
|
| Cause of Death | 2 | 2005 | 3708 | 0.060 |
Why?
|
| Pediatrics | 1 | 2019 | 3606 | 0.060 |
Why?
|
| Birth Weight | 2 | 2022 | 2121 | 0.060 |
Why?
|
| Fruit | 1 | 2009 | 1166 | 0.050 |
Why?
|
| Vegetables | 1 | 2009 | 1199 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 1936 | 0.050 |
Why?
|
| Chemoprevention | 1 | 2005 | 327 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2023 | 87 | 0.050 |
Why?
|
| Sulfasalazine | 1 | 2022 | 85 | 0.050 |
Why?
|
| Incidence | 6 | 2018 | 21480 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2009 | 1811 | 0.050 |
Why?
|
| Body Constitution | 1 | 2022 | 272 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2721 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2017 | 4544 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7425 | 0.050 |
Why?
|
| Body Composition | 1 | 2011 | 2439 | 0.050 |
Why?
|
| Malnutrition | 2 | 2018 | 629 | 0.050 |
Why?
|
| Azathioprine | 1 | 2022 | 350 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2009 | 2002 | 0.050 |
Why?
|
| Fetal Macrosomia | 1 | 2022 | 139 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2019 | 22223 | 0.050 |
Why?
|
| Karyotyping | 1 | 2023 | 1178 | 0.040 |
Why?
|
| Bile | 1 | 2021 | 300 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2022 | 291 | 0.040 |
Why?
|
| Intestines | 2 | 2022 | 1906 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2022 | 566 | 0.040 |
Why?
|
| Linear Models | 3 | 2018 | 5876 | 0.040 |
Why?
|
| Ferritins | 1 | 2023 | 600 | 0.040 |
Why?
|
| Middle East | 1 | 2020 | 237 | 0.040 |
Why?
|
| Menarche | 1 | 2023 | 532 | 0.040 |
Why?
|
| Glottis | 1 | 2021 | 212 | 0.040 |
Why?
|
| New England | 1 | 2023 | 1059 | 0.040 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3212 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2022 | 852 | 0.040 |
Why?
|
| Nausea | 1 | 2022 | 680 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2021 | 587 | 0.040 |
Why?
|
| Orosomucoid | 1 | 2018 | 47 | 0.040 |
Why?
|
| C-Reactive Protein | 2 | 2022 | 3850 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2021 | 737 | 0.040 |
Why?
|
| Phenotype | 2 | 2022 | 16721 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2018 | 360 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2020 | 751 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 13462 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2005 | 2739 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2018 | 136 | 0.030 |
Why?
|
| Pakistan | 1 | 2018 | 300 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2019 | 327 | 0.030 |
Why?
|
| Ileum | 1 | 2019 | 558 | 0.030 |
Why?
|
| Food Analysis | 1 | 2017 | 104 | 0.030 |
Why?
|
| Apgar Score | 1 | 2016 | 124 | 0.030 |
Why?
|
| Prescriptions | 1 | 2019 | 388 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 416 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 1971 | 0.030 |
Why?
|
| Infant Food | 1 | 2016 | 139 | 0.030 |
Why?
|
| Boston | 2 | 2019 | 9338 | 0.030 |
Why?
|
| Restaurants | 1 | 2018 | 235 | 0.030 |
Why?
|
| Esophageal pH Monitoring | 1 | 2017 | 203 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 1069 | 0.030 |
Why?
|
| Age of Onset | 1 | 2022 | 3344 | 0.030 |
Why?
|
| Risk | 2 | 2018 | 9591 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 1207 | 0.030 |
Why?
|
| Aged | 10 | 2018 | 171117 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2021 | 1180 | 0.030 |
Why?
|
| Time Factors | 4 | 2022 | 40065 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7478 | 0.030 |
Why?
|
| HIV Wasting Syndrome | 1 | 2014 | 99 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3423 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2887 | 0.030 |
Why?
|
| Lung | 2 | 2022 | 10033 | 0.030 |
Why?
|
| Leukocytes | 1 | 2021 | 2027 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 2016 | 738 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2015 | 469 | 0.030 |
Why?
|
| Travel | 1 | 2018 | 806 | 0.020 |
Why?
|
| Viral Load | 1 | 2021 | 3386 | 0.020 |
Why?
|
| Employment | 1 | 2018 | 1106 | 0.020 |
Why?
|
| Organ Size | 1 | 2016 | 2260 | 0.020 |
Why?
|
| Methotrexate | 1 | 2018 | 1722 | 0.020 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 4040 | 0.020 |
Why?
|
| Colon | 1 | 2019 | 1795 | 0.020 |
Why?
|
| Feces | 1 | 2018 | 1504 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2014 | 313 | 0.020 |
Why?
|
| Maternal Age | 1 | 2014 | 804 | 0.020 |
Why?
|
| Disease Progression | 2 | 2021 | 13632 | 0.020 |
Why?
|
| Infant Welfare | 1 | 2011 | 78 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2016 | 7838 | 0.020 |
Why?
|
| Cholecystitis | 1 | 2011 | 181 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5891 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3454 | 0.020 |
Why?
|
| Ulcer | 1 | 2011 | 201 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1846 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3681 | 0.020 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2009 | 52 | 0.020 |
Why?
|
| United States | 3 | 2023 | 72903 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2192 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1217 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10729 | 0.020 |
Why?
|
| Mental Health | 1 | 2023 | 3278 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3046 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2011 | 9649 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6309 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 643 | 0.020 |
Why?
|
| Marijuana Smoking | 1 | 2011 | 261 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9081 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2021 | 5993 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2015 | 4015 | 0.020 |
Why?
|
| Rural Population | 1 | 2018 | 2317 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3956 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2016 | 1950 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 674 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2116 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2019 | 3461 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15652 | 0.020 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2005 | 50 | 0.020 |
Why?
|
| Morbidity | 1 | 2011 | 1749 | 0.020 |
Why?
|
| Body Weight | 1 | 2016 | 4622 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2210 | 0.020 |
Why?
|
| Neoplasms | 2 | 2004 | 22340 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3286 | 0.010 |
Why?
|
| Cholelithiasis | 1 | 2006 | 407 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 2013 | 1384 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2016 | 2521 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2014 | 6322 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8875 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11888 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3230 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12795 | 0.010 |
Why?
|
| Aging | 1 | 2021 | 8731 | 0.010 |
Why?
|
| Flavonoids | 1 | 2005 | 448 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6499 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2009 | 1187 | 0.010 |
Why?
|
| Phenols | 1 | 2005 | 522 | 0.010 |
Why?
|
| Exercise | 1 | 2016 | 5937 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 20124 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 5508 | 0.010 |
Why?
|
| Health Promotion | 1 | 2009 | 2208 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2009 | 24282 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2004 | 1471 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 5446 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4353 | 0.000 |
Why?
|
| Animals | 1 | 2019 | 168764 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 6942 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 13451 | 0.000 |
Why?
|
Concepts
(321)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_